InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Hagan Joseph P, Chairman & CEO. Officer active across 4 companies, notably Regulus Therapeutics Inc.. Cumulatively, 8 reports have been logged. Total volume traded: €44k. The latest transaction was filed on 26 January 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
€19,037100,000 shares@ €0.190486.1% of flow
Common Stock
SEC:0001209191-22-005061·
Ideal exit: 23 Oct 2022 (T+270)
€19,037100,000 shares@ €0.190443.1% of flow
Common Stock
SEC:0001209191-22-005061:0·
Ideal exit: 23 Oct 2022 (T+270)
€178,66240,000 shares@ €4.4665100.0% of flow
Common Stock
SEC:0001628280-22-000182·
€178,66240,000 shares@ €4.46650.0085% mcap50.0% of flow
Common Stock
SEC:0001628280-22-000182:0·
015,000 shares0
Common Stock
SEC:0001567619-21-012083·
015,000 shares0
Common Stock
SEC:0001567619-21-012083:0·
€3,0654,186 shares@ €0.732113.9% of flow
Common Stock
SEC:0001209191-21-033297·
€3,0654,186 shares@ €0.73216.9% of flow
Common Stock
SEC:0001209191-21-033297:0·
8 of 8 declarations
About Hagan Joseph P
Joseph P. Hagan serves as President & CEO and Board Member at Regulus Therapeutics Inc. and Zosano Pharma Corp. In this role, he oversees the operations and strategy of both companies. His expertise in the biopharmaceutical sector allows him to contribute to innovation and growth.
